10.1002/adsc.201700234
Advanced Synthesis & Catalysis
To an oven dried Schlenk tube was charged with amide
(0.2 mmol), DMF-DMA (0.24 mmol) and DCE (2.0 mL).
The tube was closed with Teflon cap and placed in a
preheated oil bath at 60 ℃. After consumption of the
starting material (approx. 2-4 hours, monitored by TLC)
4Å molecular sieve (250 mg), Cu(OAc)2 (0.04 mmol) and
enamine (0.3 mmol) were charged and the reaction was
heated at 100 ℃ for 6-18 hours. After completion of
reaction (monitored by TLC PE/EA10:1), the mixture was
filtered through celite and washed with DCM. Organic
layer was then concentrated and the resulting residues were
purified by silica gel column chromatography (petroleum
ether/ethyl acetate) to afford the pure product.
With pyrimidine core in hand, we were interested
to explore the functional transformation reactions of
this newly synthesized pyrimidine scaffold (Scheme
2). The reaction of pyrimidine 4e with naphthalen-1-
boronic acid under the standard Suzuki cross
coupling reaction conditions gave the pyrimidine 4ea
with 78% yield, appended with a bulky naphthalene
core at the 4th position of the phenyl directly attached
to the pyrimidine ring (Scheme 2). Although the
transition metal-catalyzed decarboxylative carbon–
carbon bond formation reactions of aromatic
carboxylic acid are well established,[19-20] there are
few reports on the decarboxylative carbon–carbon
bond formation reactions of hetero-aromatic systems
mainly for activated systems such as thiophene, furan
and especially for highly privilege scaffold such as
pyrimidine are very few.[20] The palladium catalyzed
decarboxylative C-5 allylation of 4xa with ally
bromide was achieved to form the allyl pyrimidine,
4xb with 61% yield. Such pyrimidine bearing allyl
group could be useful for further functionalization.
Furthermore, the carboxylic acid 4xa can be
converted to isocyanate intermediate via Curtis
rearrangement of acyl azides. The resulting
isocyanate intermediate can serve as the precursor for
various useful amino compounds, such as urea (4xc)
Acknowledgements
We are grateful for financial support by the National Natural
Science Foundation of China (21472085) and Qing Lan
Project.We thank Heifei Zhang, Hongmio Wu and Lizheng Yang
for their support in HRMS and 19F-NMR analysis.
References
[1] For reviews, see: a) B. C. P. Jansen, W. F. Donath,
Chem. Weekblad. 1926, 23, 201; b) R. Gmelin, Z.
Hoppe-Seyler’s, Physiol. Chem. 1959, 316, 164; c) F.
Tanaka, S. Takeuchi, N. Tanaka, H. Yonehara, H.
Umezawa, Y. Sumiki, J. Antibiot. A, 1961, 14, 161; d)
E. A. Bell, R. G. Foster, Nature 1962, 194, 91; e) R. G.
S. Gerlinck, , J. C. Braekman, D. Daloze, I. Bruno, R.
Riccio, D. Rogeau, P. Amade, J. Nat. Prod. 1992, 55,
528; f) Y.-L. Lin, R.-L. Huang, C.-M. Chang, Y.-H.
Kuo, J. Nat. Prod. 1997, 60, 982; g) I. M. Lagoja,
Chem. Biodiversity 2005, 2, 1; h) J. P. Michael, Nat.
Prod. Rep. 2005, 22, 627.
and
arylamine
(4xd).
The
follow
up
chemistry/application was found to be interesting as
substituting C5 of pyrimidine is still limited.
[2] a) K. Undheim, T. Benneche, In Comprehensive
Heterocyclic ChemistryII; A. R. Katritzky, C. W. Rees,
E. F. V. Scriven, A. McKil-lop, Eds. Pergamon: Oxford,
1996; Vol. 6, p 93; b) A. W. Erian, Chem. Rev. 1993,
93, 1991; c) J. A. Joule, K. Mills, In Heterocyclic
Chemistry, 4thed.; Blackwell Science Ltd.: Cambridge,
MA, 2000, p 194.
[3] R. Mah, Pyrimidine-Based Kinase Inhibitors in Cancer
Chemotherapy. In Bioactive Heterocyclic Compound
Classes; J. Dinges, C. Lamberth, Eds.; Wiley-VCH:
Weinheim, 2012, p 257.
Scheme 2. Follow-up Chemistry
[4] K.-T. Wong, T. S. Hung, Y. Lin, C.-C.Wu, G.-H.Lee,
S.-M.Peng, C. H. Chou, Y. O. Su, Org. Lett. 2002, 4,
513.
In conclusion, a novel and versatile one-pot
synthesis of biologically interesting functionalized
pyrimidines has been developed via the copper-
catalyzed reaction of readily available primary
[5] a) M. Kitahara, N. Umeda, K. Hirano, T. Satoh, M.
Miura, J. Am. Chem. Soc. 2011, 133, 2160; b) C.-G.
Feng, M. Ye, K.-J. Xiao, S. Li, J.-Q. Yu, J. Am. Chem.
Soc. 2013, 135, 9322; c) J. Kim, S-W. Park, M-H. Baik,
S. Chang, J. Am. Chem. Soc. 2015, 137, 13448; d) M.
A. Ali, X. Yao, H. Sun, H. Lu, Org. Lett. 2015, 17,
1513; e) M. A. Ali, X. Yao, G. Li, H. Lu, Org. Lett.
2016, 18, 1386;
amides
as
building
blocks
with
N,N-
dimethylformamide dimethylacetal and enamines.
This protocol provides regioselective access to
functionally diverse pyrimidines involving C–N + C
+ N–C–C fragments and leads to [2+1+3] formal
cyclization in just one operationally friendly step.
[6] a) R. M. Dodson, J. K. Seyler, J. Org. Chem. 1951, 16,
461; b) A. L. Marzinzik, E. R. Felder, J. Org. Chem.
1998, 63, 723.
Experimental Section
4
This article is protected by copyright. All rights reserved.